1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC) : patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial
Fransson, Per ; Nilsson, Per LU
; Gunnlaugsson, Adalsteinn
LU
; Beckman, Lars
; Tavelin, Björn
; Norman, David
; Thellenberg-Karlsson, Camilla
; Hoyer, Morten
; Lagerlund, Magnus
and Kindblom, Jon
, et al.
(2021)
In The Lancet Oncology
22(2).
p.235-245
Mark
- 2020
- A Nordic-Baltic perspective on indications for proton therapy with strategies for identification of proper patients
- 2019
- Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer : 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial
- 2011
-
Particle Therapy - A next logical step in the improvement of radiotherapy
Nystrom, Hakan ; Blomqvist, Erik ; Hoyer, Morten ; Montelius, Anders ; Muren, Ludvig Paul ; Nilsson, Per LU
; Taheri-Kadkhoda, Zahra
and Glimelius, Bengt
(2011)
In Acta Oncologica
50(6).
p.741-744
Mark
- NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correction
- 2009
- Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy.
- 2008
- Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - A first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study
- 2006
- Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries